BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38212846)

  • 1. Correction: A novel transgenic mouse line with hippocampus-dominant and inducible expression of truncated human tau.
    Gao Y; Wang Y; Lei H; Xu Z; Li S; Yu H; Xie J; Zhang Z; Liu G; Zhang Y; Zheng J; Wang JZ
    Transl Neurodegener; 2024 Jan; 13(1):5. PubMed ID: 38212846
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel transgenic mouse line with hippocampus-dominant and inducible expression of truncated human tau.
    Gao Y; Wang Y; Lei H; Xu Z; Li S; Yu H; Xie J; Zhang Z; Liu G; Zhang Y; Zheng J; Wang JZ
    Transl Neurodegener; 2023 Nov; 12(1):51. PubMed ID: 37950283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load.
    Koson P; Zilka N; Kovac A; Kovacech B; Korenova M; Filipcik P; Novak M
    Eur J Neurosci; 2008 Jul; 28(2):239-46. PubMed ID: 18702695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatable transgenic mouse models of Alzheimer disease: onset, reversibility and spreading of Tau pathology.
    Hochgräfe K; Sydow A; Mandelkow EM
    FEBS J; 2013 Sep; 280(18):4371-81. PubMed ID: 23517246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical and hippocampal neurons from truncated tau transgenic rat express multiple markers of neurodegeneration.
    Filipcik P; Cente M; Krajciova G; Vanicky I; Novak M
    Cell Mol Neurobiol; 2009 Sep; 29(6-7):895-900. PubMed ID: 19263214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Truncated Tau Induces Mature Neurofibrillary Pathology in a Mouse Model of Human Tauopathy.
    Zimova I; Brezovakova V; Hromadka T; Weisova P; Cubinkova V; Valachova B; Filipcik P; Jadhav S; Smolek T; Novak M; Zilka N
    J Alzheimers Dis; 2016 Sep; 54(2):831-43. PubMed ID: 27567836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Time dependent expression profiling of PTK2B and its relationship with Aβ, Tau and LRP-1 in hippocampus and blood of APPswe/PS1dE9 double-transgenic mouse].
    Hao KM; Liu Z; Wang HY; Qi WX
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Jan; 38(1):17-24. PubMed ID: 35634664
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel triple repeat mutant tau transgenic model that mimics aspects of pick's disease and fronto-temporal tauopathies.
    Rockenstein E; Overk CR; Ubhi K; Mante M; Patrick C; Adame A; Bisquert A; Trejo-Morales M; Spencer B; Masliah E
    PLoS One; 2015; 10(3):e0121570. PubMed ID: 25803611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic and inflammatory phenotypes in transgenic tau mouse models of Alzheimer's disease and frontotemporal lobar degeneration.
    Cranston AL; Wysocka A; Steczkowska M; Zadrożny M; Palasz E; Harrington CR; Theuring F; Wischik CM; Riedel G; Niewiadomska G
    Brain Commun; 2020; 2(1):fcaa033. PubMed ID: 32954291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing exons 11 and 1 promoters of the mu opioid receptor (Oprm) gene in transgenic mice.
    Xu J; Xu M; Pan YX
    BMC Mol Biol; 2006 Nov; 7():41. PubMed ID: 17101047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
    Zhang Q; Zhang X; Sun A
    Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells.
    Jiang Y; Xu B; Chen J; Sui Y; Ren L; Li J; Zhang H; Guo L; Sun X
    Med Sci Monit; 2018 Aug; 24():5635-5644. PubMed ID: 30102687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Prion-like' propagation of mouse and human tau aggregates in an inducible mouse model of tauopathy.
    Sydow A; Mandelkow EM
    Neurodegener Dis; 2010; 7(1-3):28-31. PubMed ID: 20160454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated human mutant tau aggregation by knocking out murine tau in a transgenic mouse model.
    Ando K; Leroy K; Héraud C; Yilmaz Z; Authelet M; Suain V; De Decker R; Brion JP
    Am J Pathol; 2011 Feb; 178(2):803-16. PubMed ID: 21281813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible Expression of a Truncated Form of Tau in Oligodendrocytes Elicits Gait Abnormalities and a Decrease in Myelin: Implications for Selective CNS Degenerative Diseases.
    LoPresti P
    Neurochem Res; 2015 Nov; 40(11):2188-99. PubMed ID: 26394614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversibility of Tau-related cognitive defects in a regulatable FTD mouse model.
    Sydow A; Van der Jeugd A; Zheng F; Ahmed T; Balschun D; Petrova O; Drexler D; Zhou L; Rune G; Mandelkow E; D'Hooge R; Alzheimer C; Mandelkow EM
    J Mol Neurosci; 2011 Nov; 45(3):432-7. PubMed ID: 21822709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy models.
    Sankaranarayanan S; Barten DM; Vana L; Devidze N; Yang L; Cadelina G; Hoque N; DeCarr L; Keenan S; Lin A; Cao Y; Snyder B; Zhang B; Nitla M; Hirschfeld G; Barrezueta N; Polson C; Wes P; Rangan VS; Cacace A; Albright CF; Meredith J; Trojanowski JQ; Lee VM; Brunden KR; Ahlijanian M
    PLoS One; 2015; 10(5):e0125614. PubMed ID: 25933020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of tau phosphorylation and astroglial activation with enhanced leptin receptor expression in diet-induced obesity mouse hippocampus.
    Koga S; Kojima A; Kuwabara S; Yoshiyama Y
    Neurosci Lett; 2014 Jun; 571():11-6. PubMed ID: 24785100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental Pathogenicity of 4-Repeat Human Tau Is Lost with the P301L Mutation in Genetically Matched Tau-Transgenic Mice.
    Gamache JE; Kemper L; Steuer E; Leinonen-Wright K; Choquette JM; Hlynialuk C; Benzow K; Vossel KA; Xia W; Koob MD; Ashe KH
    J Neurosci; 2020 Jan; 40(1):220-236. PubMed ID: 31685653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegeneration caused by expression of human truncated tau leads to progressive neurobehavioural impairment in transgenic rats.
    Hrnkova M; Zilka N; Minichova Z; Koson P; Novak M
    Brain Res; 2007 Jan; 1130(1):206-13. PubMed ID: 17169350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.